Your browser doesn't support javascript.
loading
Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapy.
Tang, Qi; Zuo, Wei; Wan, Chong; Xiong, Shengwei; Xu, Chunru; Yuan, Changwei; Sun, Qiangqiang; Zhou, Liqun; Li, Xuesong.
Afiliação
  • Tang Q; Department of Urology, Peking University First Hospital, Beijing, China.
  • Zuo W; Department of Urology, Peking University First Hospital, Beijing, China.
  • Wan C; Precision Medicine Center, Yangtze Delta Region Institute of Tsinghua University, Jiaxing, Zhejiang, China.
  • Xiong S; Department of Urology, Peking University First Hospital, Beijing, China.
  • Xu C; Department of Urology, Peking University First Hospital, Beijing, China.
  • Yuan C; Department of Urology, Peking University First Hospital, Beijing, China.
  • Sun Q; Lifehealthcare Clinical Laboratory, Beijing, China.
  • Zhou L; Department of Urology, Peking University First Hospital, Beijing, China.
  • Li X; Department of Urology, Peking University First Hospital, Beijing, China.
Front Immunol ; 13: 1097730, 2022.
Article em En | MEDLINE | ID: mdl-36818471
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China